CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.07 USD
-0.14 (-0.73%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $19.06 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.07 USD
-0.14 (-0.73%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $19.06 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Zacks News
Core Labs' (CLB) Q4 Earnings Meet, Sales Miss Estimates
by Zacks Equity Research
Core Laboratories (CLB) Q4 results benefit from cost-control initiatives and operational efficiencies.
Core Laboratories (CLB) Matches Q4 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for January 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Oil & Gas Stock Roundup: ExxonMobil's Q4 Update, Core Labs' Dividend Cut & More
by Nilanjan Choudhury
Supermajor ExxonMobil (XOM) issued an update on its upcoming fourth-quarter earnings. Meanwhile, Core Labs (CLB) slashed its dividend by 55% and lowered fourth-quarter guidance.
Core Labs (CLB) Cuts Quarterly Dividend, Revises Q4 Guidance
by Zacks Equity Research
Core Labs (CLB) initiates a preliminary view for the first quarter of 2020 wherein it expects its quarterly revenues within $159-$164 million and earnings per share in the 39-41 cents range.
Why Is Core Laboratories (CLB) Up 3.6% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q3 Earnings and Sales Beat Estimates
by Zacks Equity Research
Better crude oil market fundamentals are likely to scale up international activities, thereby boosting the prospects of Core Laboratories' (CLB) Reservoir Description unit.
Core Laboratories (CLB) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 4.17% and 0.93%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
SLB & HAL Q3 Earnings Review: International Operations Strong
by Nilanjan Banerjee
Significant exposure to profitable international markets have helped Schlumberger (SLB) and Halliburton (HAL) combat weak North American operations in third-quarter 2019.
What Lies Ahead for Oilfield Service in Q3 Earnings?
by Nilanjan Banerjee
Although weak oil pricing and conservative capital spending by US explorers might have acted as headwinds in Q3, rising rig count in international market may have lent support to oilfield service.
Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Why Is Core Laboratories (CLB) Down 28.1% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs (CLB) Q2 Earnings In Line, Sales Miss Estimates
by Zacks Equity Research
Core Labs (CLB) generates FCF of $10.1 million in Q2, marking the 71st consecutive quarter that the company has generated FCF.
Core Laboratories (CLB) Meets Q2 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and -2.61%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
PUMP or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PUMP vs. CLB: Which Stock Is the Better Value Option?
Here's Why You Should Sell Core Labs (CLB) Stock Right Now
by Zacks Equity Research
Conservative capex by North American energy producers and lackluster international and offshore activities are likely to dent Core Labs' (CLB) performance in the near future.
New Strong Sell Stocks for July 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Core Laboratories (CLB) Down 19.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PUMP vs. CLB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PUMP vs. CLB: Which Stock Is the Better Value Option?
Core Labs (CLB) Surpasses Q1 Earnings and Sales Estimates
by Zacks Equity Research
Core Laboratories (CLB) expects second-quarter 2019 revenues and EPS within $172-$175 million and 47-50 cents, respectively.